Found: 7
Select item for more details and to access through your institution.
Engineered CRISPR-Cas9 nucleases with altered PAM specificities.
- Published in:
- Nature, 2015, v. 523, n. 7561, p. 481, doi. 10.1038/nature14592
- By:
- Publication type:
- Article
Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeutics.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28776-w
- By:
- Publication type:
- Article
Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeutics.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28776-w
- By:
- Publication type:
- Article
Defining genome-wide CRISPR–Cas genome-editing nuclease activity with GUIDE-seq.
- Published in:
- Nature Protocols, 2021, v. 16, n. 12, p. 5592, doi. 10.1038/s41596-021-00626-x
- By:
- Publication type:
- Article
Open-source guideseq software for analysis of GUIDE-seq data.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 5, p. 483, doi. 10.1038/nbt.3534
- By:
- Publication type:
- Article
Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 12, p. 1293, doi. 10.1038/nbt.3404
- By:
- Publication type:
- Article
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 2, p. 187, doi. 10.1038/nbt.3117
- By:
- Publication type:
- Article